Page 181 - BSAVA Guide to Pain Management in Small Animal Practice
P. 181

BSAVA Guide to Pain Management in Small Animal Practice



        VetBooks.ir  Drug  Notes*                          Dose     Author
                                                                    recommendations
                                                           range in
                                                           literature*
                                                                    and guidance
            Opioids
             orphine  •  Relatively short acting mu receptor agonist   .1 mg to    .1  .  mg kg i.m.    4h
                      •  Infre uently used due to con icting early studies;       mg   could be used but other
                        even strain dependent di erences in the same   kg  opioid options may be
                        species are reported                        better
                      •   here are reductions in  AC with increasing doses
                          .1, 1 and   mg kg  and anecdotal reports of
                        analgesia at  normal  clinical doses but not well
                        evaluated
             entanyl  •  Very short acting mu receptor agonist with a fast   1        Use at the doses in the
                        elimination making it more suitable as a CRI    g kg min  literature should be
                      •   .  mg kg s.c. was e ective but caused     accompanied by careful
                        hyperexcitability                           monitoring of cardio
                      •  CRI in red tailed hawks reduced  AC without   vascular parameters
                        signi cant cardiovascular e ects
            Butorphanol  •   ixed agonist antagonist with low intrinsic activity at    .  6    1 4 mg kg i.m.    4h
                        the mu receptor and strong agonist activity at the   mg kg  depending on pain
                        kappa receptor                              assessment
                      •   ne of the most commonly used opioids in birds   Use with care and at
                        despite the reported need for fre uent dosing  lower end of the dose
                      •  Not associated with dysphoria that is seen in   range for birds of prey
                        mammals                                     Can prolong recovery
                      •   ose ranges in literature from  .  6 mg kg   more   from anaesthesia
                        usually 1 4 mg kg used clinically in psittacines
                      •   inimal e cacy in American kestrels
                      •   re uency is empirical but studies suggest    4h
                        may be re uired
            Bupre     •  Slow onset, long acting; thought to act as a partial    .1  .6    .   .  mg kg i.m.  6h
            norphine    mu agonist but its kappa receptor activities are   mg kg  Use the lower end of
                        uncertain                                   dose range for birds of
                      •   issociation from binding sites is slow    prey to avoid increased
                      •  No e ect at  .1 mg kg in African grey parrots  sedation without
                      •  Some e ect at  .   mg kg and more at  .  mg kg in   additional analgesia
                        pigeons                                     Some believe it has no
                      •  E ective at  .1  .6 mg kg in American kestrels for    e ect and blocks other
                        up to 6 hours with sedation at the top end of the   opioids
                        dosing range
                      •   ore data in other species needed

            Nalbuphine  •  Newer human kappa agonist and partial mu   1 .     Refer to literature dose
                        antagonist                         mg kg
                      •  E ective at 1 .  mg kg i.m. for   hours in  ispaniolan
                        parrots


                  Analgesia drugs used in birds.  Information referenced from  awkins et al.,   16. CRI   continuous rate
               3   infusion;  AC   mean anaesthetic concentration; NSAI    non steroidal anti in ammatory drug;
           P    pharmacodynamic; P    pharmacokinetic.  continues

           176



         Ch07J Pain Management.indd   176                                       19/12/2018   10:47
   176   177   178   179   180   181   182   183   184   185   186